What is the NOAEL for Piroctone olamine?
Piroctone olamine has 36 NOAEL studies in the database. The lowest reported value is 12.3 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Also known as: EINECS 272-574-2, Octopirox, UNII-A4V5C6R9FB, Kopirox
CAS 68890-66-4
Piroctone olamine (CAS 68890-66-4) is a chemical substance. Key regulatory status: REACH registered, 3 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
Piroctone olamine is classified GHS Danger (H315, H318, H335, H400, H410, H412) in the chemicals database but is restricted in EU cosmetics at max 1.0% rinse-off / 0.5% leave-on.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| active_ingredient; Europe; Pesticides | Commission of the European Communities | CPCat |
| Europe; Personal care - hair styling and care - shampoo-dandruff | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care - hair styling and care - shampoo-dandruff | Danish Environmental Protection Agency | Danish EPA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =12.3 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =14.7 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| A4V5C6R9FB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| A4V5C6R9FB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| A4V5C6R9FB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| A4V5C6R9FB | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =225 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =1 | % | NOAEL | dermal | human | SCCNFP_vision_codex |
| =1 | % | NOAEL | dermal | human | SCCNFP_vision_codex |
| =1 | % | NOAEL | dermal | human | SCCNFP_vision_codex |
| =1 | % | NOAEL | dermal | human | SCCNFP_vision_codex |
| =16 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =16 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =16 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =16 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =100 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =100 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =100 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =100 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =100 | mg/kg/day | NOAEL | oral | rat | SCCNFP_vision_codex |
| =225 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =250 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| <2000 | mg/kg bw/day | NOAEL | injection | Rat | ToxValDB_ECHA_IUCLID |
| >=2 | mg/cm2-day | NOEL | dermal | Rat | ToxValDB_ECHA_IUCLID |
| >=55 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| >63 | mg/kg bw/day | NOEL | oral | Rabbit | ToxValDB_ECHA_IUCLID |
| >=100 | mg/cm2-day | NOEL | dermal | Rabbit | ToxValDB_ECHA_IUCLID |
| >=100 | mg/kg bw/day | NOEL | dermal | Rat | ToxValDB_ECHA_IUCLID |
| >=210 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| >=500 | mg/kg bw/day | NOEL | injection | Rat | ToxValDB_ECHA_IUCLID |
| >=2000 | mg/kg bw/day | NOEL | injection | Rat | ToxValDB_ECHA_IUCLID |
| 1 | % | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
| 1 | % | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
| 1 | % | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
| 16 | mg/kg/day | developmental toxicity | oral | rat | UnifiedCodex:SCCNFP:beta.noael_studies |
| 100 | mg/kg/day | developmental toxicity | oral | rat | UnifiedCodex:SCCNFP:beta.noael_studies |
Showing 36 of 36 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1) | 272-574-2 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Piroctone olamine has 36 NOAEL studies in the database. The lowest reported value is 12.3 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Piroctone olamine appears on 2 regulatory/inventory lists including active_ingredient; Europe; Pesticides, Europe; Personal care - hair styling and care - shampoo-dandruff. Source: EPA CPDat.
Yes, Piroctone olamine is also indexed as a cosmetic ingredient under the name Piroctone Olamine. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Piroctone olamine is classified GHS Danger (H315, H318, H335, H400, H410, H412) in the chemicals database but is restricted in EU cosmetics at max 1.0% rinse-off / 0.5% leave-on.
Piroctone olamine also appears in cosmetics, pharmaceutical databases.